ELIZABETH GLEIXNER: Open Payments
NPI 1720505639 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 8 payments from 8 companies in 2025. Trend: 2023 $444 · 2024 $837 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $163 |
| Sequel Med Tech, LLC | 1 | $134 |
| Neurocrine BioSciences, Inc. | 1 | $131 |
| SANOFI-AVENTIS U.S. LLC | 1 | $126 |
| Ascendis Pharma Endocrinology Inc | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| Insulet Corporation | 1 | $112 |
| CeQur Corporation | 1 | $71 |
Products named: MINIMED 780G, TWIIST, CRENESSITY, TZIELD, Yorvipath, Kerendia, OMNIPOD, CeQur Simplicity.
Industry payments across KY — which companies pay providers there.
